{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:24:07Z","timestamp":1744172647170,"version":"3.40.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,8]]},"DOI":"10.7759\/cureus.81902","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:52:39Z","timestamp":1744134759000},"source":"Crossref","is-referenced-by-count":0,"title":["Temporal Trends in the Management and Mortality Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales: A Cohort Study"],"prefix":"10.7759","author":[{"given":"Gon\u00e7alo","family":"Pinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Bartilotti Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gorgulho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Ramdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Malheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2900\/8752612","article-title":"Carbapenem-resistant Enterobacterales - third update, 3 February 2025","author":"European Centre for Disease Prevention and Control","year":"2025","unstructured":"European Centre for Disease Prevention and Control. Carbapenem-resistant Enterobacterales, third update - 3 February 2025. European Centre for Disease Prevention and Control, Stockholm, Sweden; 2025. 10.2900\/8752612"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11030373","article-title":"Meropenem\/vaborbactam plus aztreonam as a possible treatment strategy for bloodstream infections caused by ceftazidime\/avibactam-resistant Klebsiella pneumoniae: a retrospective case series and literature review","volume":"11","author":"Belati A","year":"2022","unstructured":"Belati A, Bavaro DF, Diella L, De Gennaro N, Di Gennaro F, Saracino A. Meropenem\/vaborbactam plus aztreonam as a possible treatment strategy for bloodstream infections caused by ceftazidime\/avibactam-resistant Klebsiella pneumoniae: a retrospective case series and literature review. Antibiotics (Basel). 2022, 11:373. 10.3390\/antibiotics11030373","journal-title":"Antibiotics (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103998","article-title":"Klebsiella species: taxonomy, hypervirulence and multidrug resistance","volume":"79","author":"Dong N","year":"2022","unstructured":"Dong N, Yang X, Chan EW, Zhang R, Chen S. Klebsiella species: taxonomy, hypervirulence and multidrug resistance. EBioMedicine. 2022, 79:103998. 10.1016\/j.ebiom.2022.103998","journal-title":"EBioMedicine"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2025.128049","article-title":"Rapid emergence, transmission, and evolution of KPC and NDM coproducing carbapenem-resistant Klebsiella pneumoniae","volume":"293","author":"Li J","year":"2025","unstructured":"Li J, Wu W, Wu H, et al.. Rapid emergence, transmission, and evolution of KPC and NDM coproducing carbapenem-resistant Klebsiella pneumoniae. Microbiol Res. 2025, 293:128049. 10.1016\/j.micres.2025.128049","journal-title":"Microbiol Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-51118-9","article-title":"Comparison of mortality rates in patients with carbapenem-resistant Enterobacterales bacteremia according to carbapenemase production: a multicenter propensity-score matched study","volume":"14","author":"Baek MS","year":"2024","unstructured":"Baek MS, Kim JH, Park JH, Kim TW, Jung HI, Kwon YS. Comparison of mortality rates in patients with carbapenem-resistant Enterobacterales bacteremia according to carbapenemase production: a multicenter propensity-score matched study. Sci Rep. 2024, 14:597. 10.1038\/s41598-023-51118-9","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00008-23","article-title":"Klebsiella pneumoniae carbapenemase variants: the new threat to global public health","volume":"36","author":"Ding L","year":"2023","unstructured":"Ding L, Shen S, Chen J, et al.. Klebsiella pneumoniae carbapenemase variants: the new threat to global public health. Clin Microbiol Rev. 2023, 36:e0000823. 10.1128\/cmr.00008-23","journal-title":"Clin Microbiol Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127839","article-title":"Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: a global public health threat","volume":"288","author":"Lei TY","year":"2024","unstructured":"Lei TY, Liao BB, Yang LR, Wang Y, Chen XB. Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: a global public health threat. Microbiol Res. 2024, 288:127839. 10.1016\/j.micres.2024.127839","journal-title":"Microbiol Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1157010","article-title":"Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis","volume":"13","author":"Li D","year":"2023","unstructured":"Li D, Huang X, Rao H, Yu H, Long S, Li Y, Zhang J. Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2023, 13:1157010. 10.3389\/fcimb.2023.1157010","journal-title":"Front Cell Infect Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment options for carbapenem-resistant Gram-negative bacterial infections","volume":"69","author":"Doi Y","year":"2019","unstructured":"Doi Y. Treatment options for carbapenem-resistant Gram-negative bacterial infections. Clin Infect Dis. 2019, 69:S565-75. 10.1093\/cid\/ciz830","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00179-13","article-title":"Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae","volume":"57","author":"Tascini C","year":"2013","unstructured":"Tascini C, Tagliaferri E, Giani T, et al.. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2013, 57:3990-3. 10.1128\/AAC.00179-13","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.756580","article-title":"Emergence of colistin resistance in carbapenem-resistant hypervirulent Klebsiella pneumoniae under the pressure of tigecycline","volume":"12","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Wang X, Wang S, et al.. Emergence of colistin resistance in carbapenem-resistant hypervirulent Klebsiella pneumoniae under the pressure of tigecycline. Front Microbiol. 2021, 12:756580. 10.3389\/fmicb.2021.756580","journal-title":"Front Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab176","article-title":"Ceftazidime-avibactam use for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infections: a retrospective observational multicenter study","volume":"73","author":"Tumbarello M","year":"2021","unstructured":"Tumbarello M, Raffaelli F, Giannella M, et al.. Ceftazidime-avibactam use for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae infections: a retrospective observational multicenter study. Clin Infect Dis. 2021, 73:1664-76. 10.1093\/cid\/ciab176","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1155","article-title":"Monitoring ceftazidime-avibactam and aztreonam concentrations in the treatment of a bloodstream infection caused by a multidrug-resistant Enterobacter sp. carrying both Klebsiella pneumoniae carbapenemase-4 and New Delhi metallo-\u03b2-lactamase-1","volume":"71","author":"Yasmin M","year":"2020","unstructured":"Yasmin M, Fouts DE, Jacobs MR, et al.. Monitoring ceftazidime-avibactam and aztreonam concentrations in the treatment of a bloodstream infection caused by a multidrug-resistant Enterobacter sp. carrying both Klebsiella pneumoniae carbapenemase-4 and New Delhi metallo-\u03b2-lactamase-1. Clin Infect Dis. 2020, 71:1095-8. 10.1093\/cid\/ciz1155","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.31744\/einstein_journal\/2019GS4444","article-title":"Economic burden of inpatients infected with Klebsiella pneumoniae carbapenemase","volume":"17","author":"Santos WM","year":"2019","unstructured":"Santos WM, Secoli SR. Economic burden of inpatients infected with Klebsiella pneumoniae carbapenemase. Einstein (Sao Paulo). 2019, 17:eGS4444. 10.31744\/einstein_journal\/2019GS4444","journal-title":"Einstein (Sao Paulo)"},{"key":"ref15","unstructured":"The European Committee on Antimicrobial Susceptibility Testing - EUCAST. (2025). Accessed. March 23, 2025: http:\/\/www.eucast.org."},{"key":"ref16","unstructured":"Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - 2022-2023. (2024). Accessed. March 23, 2025: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/PPS-HAI-AMR-acute-care-europe-2022-2023."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.02.007","article-title":"Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: systematic review and meta-analysis: mortality due to KPC Klebsiella pneumoniae infections","volume":"76","author":"Ramos-Casta\u00f1eda JA","year":"2018","unstructured":"Ramos-Casta\u00f1eda JA, Ruano-Ravina A, Barbosa-Lorenzo R, Paillier-Gonzalez JE, Salda\u00f1a-Campos JC, Salinas DF, Lemos-Luengas EV. Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: systematic review and meta-analysis: mortality due to KPC Klebsiella pneumoniae infections. J Infect. 2018, 76:438-48. 10.1016\/j.jinf.2018.02.007","journal-title":"J Infect"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.53986\/ibjm.2022.0020","article-title":"Rising incidence of carbapenem resistant isolates: an Argentinian hospital\u2019s experience. More trouble in the aftermath of the COVID-19 pandemic","volume":"4","author":"Castro MG","year":"2022","unstructured":"Castro MG, Ubiergo L, Vicino M, Cuevas G, Argara\u00f1\u00e1 F. Rising incidence of carbapenem resistant isolates: an Argentinian hospital\u2019s experience. More trouble in the aftermath of the COVID-19 pandemic. Iberoam J Med. 2022, 4:92-9. 10.53986\/ibjm.2022.0020","journal-title":"Iberoam J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102729","article-title":"Impact of the COVID-19 pandemic on healthcare-associated infections and multidrug-resistant microorganisms in Italy: a systematic review","volume":"18","author":"Peconi C","year":"2025","unstructured":"Peconi C, Martini E, Sarti D, Prospero E. Impact of the COVID-19 pandemic on healthcare-associated infections and multidrug-resistant microorganisms in Italy: a systematic review. J Infect Public Health. 2025, 18:102729. 10.1016\/j.jiph.2025.102729","journal-title":"J Infect Public Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2024.10.046","article-title":"The influence of COVID-19 on the incidence and antimicrobial resistance of multi-drug resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii in a tertiary care hospital in Belgrade (Serbia)","volume":"39","author":"Savic P","year":"2024","unstructured":"Savic P, Gostimirovic M, Vitorovic T, Rajkovic J, Bukarica A, Gojkovic-Bukarica L. The influence of COVID-19 on the incidence and antimicrobial resistance of multi-drug resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii in a tertiary care hospital in Belgrade (Serbia). J Glob Antimicrob Resist. 2024, 39:15. 10.1016\/j.jgar.2024.10.046","journal-title":"J Glob Antimicrob Resist"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1086\/675718","article-title":"Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update","volume":"35","author":"Lo E","year":"2014","unstructured":"Lo E, Nicolle LE, Coffin SE, et al.. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014, 35:464-79. 10.1086\/675718","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul M","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, et al.. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022, 28:521-47. 10.1016\/j.cmi.2021.11.025","journal-title":"Clin Microbiol Infect"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma PD","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections. Clin Infect Dis. 2024, ciae403. 10.1093\/cid\/ciae403","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1249030","article-title":"In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review","volume":"10","author":"Aslan AT","year":"2023","unstructured":"Aslan AT, Ezure Y, Horcajada JP, Harris PN, Paterson DL. In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review. Front Med (Lausanne). 2023, 10:1249030. 10.3389\/fmed.2023.1249030","journal-title":"Front Med (Lausanne)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.03.011","article-title":"Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae","volume":"23","author":"P\u00e9rez-Nadales E","year":"2023","unstructured":"P\u00e9rez-Nadales E, Fern\u00e1ndez-Ruiz M, Natera AM, et al.. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae. Am J Transplant. 2023, 23:1022-34. 10.1016\/j.ajt.2023.03.011","journal-title":"Am J Transplant"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00883-17","article-title":"Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia","volume":"61","author":"Shields RK","year":"2017","unstructured":"Shields RK, Nguyen MH, Chen L, et al.. Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother. 2017, 61:e00883-17. 10.1128\/AAC.00883-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00762-9","article-title":"The use and effectiveness of ceftazidime-avibactam in real-world clinical practice: EZTEAM study","volume":"12","author":"Soriano A","year":"2023","unstructured":"Soriano A, Montravers P, Bassetti M, et al.. The use and effectiveness of ceftazidime-avibactam in real-world clinical practice: EZTEAM study. Infect Dis Ther. 2023, 12:891-917. 10.1007\/s40121-023-00762-9","journal-title":"Infect Dis Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad280","article-title":"Efficacy and safety of ceftazidime\/avibactam in patients with infections caused by \u03b2-lactamase-producing Gram-negative pathogens: a pooled analysis from the phase 3 clinical trial programme","volume":"78","author":"Torres A","year":"2023","unstructured":"Torres A, Wible M, Tawadrous M, et al.. Efficacy and safety of ceftazidime\/avibactam in patients with infections caused by \u03b2-lactamase-producing Gram-negative pathogens: a pooled analysis from the phase 3 clinical trial programme. J Antimicrob Chemother. 2023, 78:2672-82. 10.1093\/jac\/dkad280","journal-title":"J Antimicrob Chemother"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2742-9","article-title":"Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae","volume":"24","author":"Falcone M","year":"2020","unstructured":"Falcone M, Bassetti M, Tiseo G, et al.. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care. 2020, 24:29. 10.1186\/s13054-020-2742-9","journal-title":"Crit Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/355659-temporal-trends-in-the-management-and-mortality-associated-with-klebsiella-pneumoniae-carbapenemase-producing-enterobacterales-a-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:52:41Z","timestamp":1744134761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/355659-temporal-trends-in-the-management-and-mortality-associated-with-klebsiella-pneumoniae-carbapenemase-producing-enterobacterales-a-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.81902","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,8]]}}}